Literature DB >> 19936483

[Five-year survival and prognostic factors in a cohort of breast cancer patients treated in Juiz de Fora, Minas Gerais State, Brazil].

Maximiliano Ribeiro Guerra1, Gulnar Azevedo E Silva Mendonça, Maria Teresa Bustamante-Teixeira, Jane Rocha Duarte Cintra, Lilian Marzullo de Carvalho, Lydia Maria Pereira Vaz de Magalhães.   

Abstract

The purpose of this study was to analyze five-year survival and the main prognostic factors among women with invasive breast cancer diagnosed from 1998 to 2000 that had undergone surgical treatment in the city of Juiz de Fora, Minas Gerais State, Brazil. Study variables were: age, skin color, place of residence, tumor-related variables, and treatment-related variables. Survival functions were calculated by the Kaplan-Meier method, and multivariate analysis was performed using the Cox proportional hazard model. Disease-specific survival was 81.8%. Tumor size and lymph node involvement were the main independent prognostic factors in the study population, with increased risk of death for women with tumor size greater than 2.0 cm (HR = 1.97; 95%CI: 1.26-3.07) and positive axillary lymph nodes (HR = 4.04; 95%CI: 2.55-6.39). The results emphasize the need for earlier diagnosis and treatment. Access to screening at different levels of care, mainly for women at high risk, should be a key priority for the Unified National Health System in Brazil.

Entities:  

Mesh:

Year:  2009        PMID: 19936483     DOI: 10.1590/s0102-311x2009001100015

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  7 in total

1.  Axillary web syndrome is not a risk factor for lymphoedema after 10 years of follow-up.

Authors:  Bárbara Reis Wariss; Rejane Medeiros Costa; Ana Carolina Padula Ribeiro Pereira; Rosalina Jorge Koifman; Anke Bergmann
Journal:  Support Care Cancer       Date:  2016-10-04       Impact factor: 3.603

Review 2.  A review of breast cancer care and outcomes in Latin America.

Authors:  Nahila Justo; Nils Wilking; Bengt Jönsson; Silvana Luciani; Eduardo Cazap
Journal:  Oncologist       Date:  2013-02-26

3.  Quality of life as a predictor of overall survival after breast cancer treatment.

Authors:  Suzana Sales De Aguiar; Anke Bergmann; Inês Echenique Mattos
Journal:  Qual Life Res       Date:  2013-07-20       Impact factor: 4.147

4.  Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.

Authors:  Daniella M F Paiva; Vivian O Rodrigues; Marcelle G Cesca; Pamella V Palma; Isabel C G Leite
Journal:  BMC Womens Health       Date:  2013-02-13       Impact factor: 2.809

5.  Histological profile and age at diagnosis of breast and ovarian tumors: A register-based study in Espirito Santo, Brazil.

Authors:  Eldamária DE Vargas Wolfgramm; Camila Fátima Biancardi Gavioli; Mayara Lemos Entringer; Lyvia Neves Rebello Alves; Elaine Stur; Allan Kardec DE Castro Neto; Luciene Lage DA Motta; Fausto Edmundo Lima Pereira; Iuri Drumond Louro
Journal:  Mol Clin Oncol       Date:  2012-11-05

6.  Effect of Agaricus sylvaticus supplementation on nutritional status and adverse events of chemotherapy of breast cancer: a randomized, placebo-controlled, double-blind clinical trial.

Authors:  Fabiana Valadares; Maria Rita Carvalho Garbi Novaes; Roberto Cañete
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

7.  Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality.

Authors:  Débora Balabram; Cassio M Turra; Helenice Gobbi
Journal:  BMC Cancer       Date:  2013-09-24       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.